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Introduction
Cells sense their location and respond to the environment 
through integrin-containing adhesion complexes located at the 
plasma membrane (Zaidel-Bar et al., 2007). Adhesion com-
plexes  control  cell  architecture  and  migration  and  integrate 
microenvironmental signals with those from soluble factors to 
influence cell fate decisions (Streuli and Akhtar, 2009). How-
ever, how integrin signaling determines cell phenotype is not 
fully understood. This problem is compounded by the com-
plexity of the assembly and the variety of adaptor proteins that 
bind to integrin cytoplasmic tails as well as differences between 
adhesions among cell lineages (Zaidel-Bar et al., 2007; Legate 
and Fässler, 2009).
Most adherent cells require integrins to progress through 
the cell cycle. Genetic deletion of integrins in vivo and culture 
has revealed their key role for the proliferation of many cell 
types (Wickström et al., 2011). In the mammary gland, 1 inte-
grin is needed for efficient proliferation in both development 
and cancer (Li et al., 2005; Lahlou et al., 2007). Integrins 
control growth factor signaling pathways in some cell types, 
whereas in others, they activate enzymes that are necessary for 
the G1 phase of the cell cycle (Giancotti and Tarone, 2003; 
Bustelo et al., 2007). Integrins therefore provide an adhesion 
checkpoint for cell cycle progression (Streuli, 2009). However, 
the proximal adhesion complex proteins that link integrins with 
proliferation are not known. Here, we ask whether a core pro-
tein of adhesion complexes, talin, might be directly involved in 
linking integrins with cell cycle progression.
Talin is a ubiquitous integrin-interacting scaffold pro-
tein at cell–matrix attachment sites, containing N-terminal 
globular head and C-terminal rod domains. Talin activates 
integrins and connects integrins to the actomyosin machin-
ery (Critchley, 2009). It provides inside-out signals by inter-
acting with the integrin cytoplasmic region through its head 
domain causing / integrin chain separation. This activity 
allows talin to regulate the ECM-binding activity of integrins 
(Tadokoro et al., 2003; Simonson et al., 2006; Nieswandt   
et al., 2007; Watanabe et al., 2008; Anthis et al., 2009; Lee   
et al., 2009; Ye et al., 2010). Talin also connects integrins 
with the cytoskeleton via the adaptor protein vinculin. This 
imparts mechanical stability to the adhesions between muscle 
cells and tendons (Gingras et al., 2008; Löer et al., 2008; 
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affected by talin1 depletion with shTln1. Similarly, knocking 
down talin had no effect on MEC adhesion to a variety of 
other ECM substrata, including laminin, vitronectin, or collagen I 
(Fig. 2 A, right).
These results suggest that integrins are still active in talin-
depleted MECs. Indeed, 1 integrin–containing adhesions were 
present in both control and talin-depleted MECs by immuno-
staining with 9EG7, a monoclonal antibody to a conformation-
specific epitope that is only exposed on activated 1 integrin 
(Fig. 2 B; Lenter et al., 1993). Thus, although the extent to 
which talin was knocked down did not prevent integrin-mediated 
attachment, it did impair cell cycle progression.
We therefore examined the possibility that the cell cycle 
defects might be related to altered cytoskeleton or cell shape. 
Adhesion complexes are sites of cytoskeleton assembly, where 
microfilaments are built through interactions with integrin- and 
actin-binding proteins, such as talin (Carisey and Ballestrem, 
2011). Interestingly, we found that in MECs, talin depletion had 
no apparent effect on the presence of stress fibers (Fig. 2 C, top 
and bottom left). Quantifying the intensity of F-actin fluorescence 
per micrometer squared revealed that levels of microfilaments 
were similar in the presence and absence of talin (Fig. 2 C, bottom 
right). Because one of talin’s functions is to link integrins with 
the cytoskeleton, we assessed whether other proteins might 
substitute for the lack of talin. One possible linker is tensin 
because some of the GFP-tensin expressed in MECs relocated 
from stress fibers in control cells to adhesions in talin1-depleted 
cells (Fig. S3).
The cell cycle regulation of many cell types is dependent 
on cell size, and proliferation can be blocked when spreading 
is compromised (Chen et al., 1997). Thus, although microfila-
ments were still present in talin-depleted MECs, proliferation 
might be prevented if the cells cannot spread appropriately. To 
examine the possibility that talin depletion inhibited cell cycle 
progression by preventing a full degree of spreading, we mea-
sured the sizes of several hundred GFP- or shTln1 virus-infected 
MECs and compared this with the ability of the same cells to 
incorporate BrdU. There was a broad range of cell spread area 
in these particular cultures, and their spreading was marginally 
affected in talin-depleted cells (Fig. 3 A, left). However, regard-
less of cell spread area, in each case, their cell cycle was simi-
larly inhibited (Fig. 3 A, right). To confirm that defective cell 
spreading was not the cause of the proliferation defect, MECs 
expressing GFP or shTln1 were spread on adhesive 225-µm
2  
islands. Under these conditions of identical spreading, talin1 
was still required for the cells to transduce the adhesion path-
ways for DNA synthesis (Fig. 3 B).
These results indicate that the requirement of talin for 
mammary cell cycle progression is not dependent on cell archi-
tecture. We therefore reasoned that talin might be required to 
recruit additional adhesion complex proteins, which are impor-
tant for proliferation. The ability of MECs to spread on tissue 
culture dishes after talin knockdown enabled us to search for 
adhesion components that are affected by the absence of talin 
and that potentially link integrins to cell proliferation pathways. 
Talin binds vinculin, which is a core adaptor protein within 
integrin adhesions (Critchley, 2009). Vinculin was not present 
Critchley, 2009; Carisey and Ballestrem, 2011). In addition, 
talin  transmits  forces  from  the  ECM  to  the  cytoskeleton, 
which enables focal adhesion formation and cell spreading 
(Giannone et al., 2003; Zhang et al., 2008). We now demon-
strate that talin is necessary for transducing integrin-regulated 
pathways to control cell cycle progression in mammary epi-
thelial cells (MECs) and that this activity is contained within 
the C-terminal portion of its rod domain.
Results
Talin links integrins to epithelial  
cell proliferation
To determine the function of talin in epithelia, we took ad-
vantage of FSK7, MEC strain isolated from virgin mice that 
synthesizes talin1 but not its homologue talin2 (Fig. S1 A). 
Lentiviral  small  hairpin  RNA  (shRNA)  directed  against  talin1   
(shTln1)  depleted  talin  by  90%  in  MECs  as  detected  by   
immunoblotting (Fig. 1 A) and to nearly undetectable levels 
in adhesion complexes when analyzed by immunofluorescence 
(Fig. 1 B, top). Similar effects were seen with two separate 
shTln1 sequences (Fig. S1 B, top).
In mouse embryonic fibroblasts, talin depletion led to 
a complete inhibition of cell spreading, confirming that our 
shRNA sequences for talin1 have a similar efficacy as previ-
ously shown by others (Fig. S2; Zhang et al., 2008). In con-
trast to fibroblasts, MECs lacking talin remained spread on the 
tissue culture dishes (Fig. 1 B, bottom). However the density 
of these spread cells did not increase over several days, and 
because apoptotic cells were not present, we hypothesized that 
talin depletion caused a proliferation block. To test this pos-
sibility, we stained subconfluent cultures with BrdU, EdU, or 
phospho-Histone3 and found that shTln1 reduced the propor-
tion of cells undergoing DNA synthesis (Fig. 1 C). To confirm 
that talin depletion was specifically involved with cell cycle 
arrest, we coexpressed a human talin cDNA that could not be 
targeted by mouse shTln1. This vector rescued cell cycle arrest 
caused by shTln1 (Fig. 1 D). Talin depletion also caused a pro-
liferation defect in another mammary epithelial line that causes 
malignant lesions in vivo, 4T1 (Fig. 1 E). A scrambled version 
of the shTln1 sequence did not deplete talin in MECs nor did it 
prevent proliferation (Fig. S1 C).
These data suggest that talin provides a link between inte-
grins and downstream cellular processes that control the prolif-
eration of MECs. In the subsequent experiments, we dissected 
the mechanism for outside-in signaling via talin.
Talin coordinates the assembly of core 
epithelial adhesion complex proteins
Because 1 integrins are required for MEC proliferation (Li   
et al., 2005; Naylor et al., 2005), we tested whether shTln1 
simply prevented integrin activation. To determine the contri-
bution of 1 integrin to MEC adhesion, endogenous 1 integrin 
was depleted with a microRNA-adapted shRNA (shRNAmir). 
Approximately 80% of the attachment was prevented, reflect-
ing the key role of 1 integrins to MEC adhesion (Fig. 2 A, 
left and middle). In contrast, adhesion was only marginally 501 Talin’s C terminus controls cell cycle • Wang et al.
Figure 1.  Talin1 is required for MEC proliferation. 
(A, left) MECs were infected with either shTln1 or GFP-
only lentivirus or mock infected (3 h), cultured (48 h),   
FACS  sorted  to  isolate  GFP+  cells,  and  immuno-
blotted  with  antibodies  to  talin1,  1  integrin,  and 
actin. (right) Relative talin levels were quantified by 
an infrared imaging system (Odyssey; LI-COR Biosci-
ences; actin is the loading control). Note that in this 
and subsequent figures, n = 3 or more independent 
experiments. (B) Mock, GFP-only, or shTln1-infected 
cells were cultured for 48 h, replated, cultured a fur-
ther 72 h, and then examined by fluorescence (top) 
and  phase-contrast  microscopy  (bottom).  The  talin- 
depleted cells spread but did not become confluent. 
Talin  localized  to  adhesions  of  uninfected  MECs 
(red) but was absent in shTln1-infected cells (green).   
(C) GFP-only or shTln1-infected cells were replated, 
cultured overnight, and labeled with BrdU (2 h) or 
stained  for  phospho-Histone3.  (left)  Representative 
field after BrdU labeling. The arrow points to GFP-
positive  cells  in  S  phase,  whereas  the  arrowhead 
shows that the GFP-positive cells in talin knockdown 
cells did not incorporate BrdU into their DNA. Quan-
tification of proliferation in infected cells was GFP 
only = 60 ± 5.9% and shTln1/GFP = 21 ± 3.6%. 
(right)  Quantification  of  proliferation  by  phospho-
Histone3  (pH3+)  in  infected  cells.  (D)  MECs  were 
cotransfected with either shTln1 or empty pLVTHM 
plasmid (pLV) together with shRNA-resistant human 
full-length  talin1  (tlnFL),  cultured  (48  h),  replated 
(overnight), and labeled with EdU (2 h). EdU+ cells   
were quantified in both the infected (GFP) and un-
infected (unin) control cells on the same dishes. (E) GFP- 
only  or  shTln1-infected  4T1  cells  were  cultured   
(48 h), FACS sorted to isolate GFP+ cells, and either 
immunoblotted with antibodies to talin1 and actin or 
cultured overnight and labeled with BrdU (2 h). Error 
bars indicate SEM. Bars: (B, top) 20 µm; (B, bottom) 
100 µm; (C) 50 µM.JCB • VOLUME 195 • NUMBER 3 • 2011   502
Figure 2.  Depletion of talin1 does not affect 1 integrin activation or the MEC cytoskeleton. (A, left and middle) Cells were cotransfected with shRNAmir 
for 1 integrin (sh-1mir), shRNA for talin1 (shTln1), and the empty vectors (pLB2 and pLVTHM [pLV]). After 48 h, GFP-positive cells sorted by FACS were 
used in an adhesion assay on FN. (left) Blot showing that both 1 integrin and talin1 proteins were effectively deleted by using shRNA. (middle) Depletion 
of 1 integrin almost completely blocked cell attachment, but in contrast, talin knockdown only slightly reduced adhesion. (right) GFP-only or shTln1-infected 
MECs were FACS sorted to isolate GFP+ cells and used for adhesion assays on FN, laminin (LM), vitronectin (VN), or collagen I (CO). (B, top) FACS-sorted 
GFP-only or shTln1-infected cells were cultured overnight and stained for 1 integrin and phalloidin. (bottom) Costaining of talin with F-actin in shTln1-
infected cells. (bottom left) Representative images. (bottom right) The intensity of total actin fluorescence per micrometer squared in control GFP-negative 
cells and in cells with talin knockdown (GFP positive). The GFP-positive cells depleted of talin showed normal microfilament distribution (arrows). The yellow 
lines demarcate the cell periphery. (C) FACS-sorted GFP-only or shTln1-infected cells were cultured overnight, briefly detergent extracted before fixation, 
and stained for either total (top) or active (bottom) 1 integrin (9EG7). Arrows point to 1 integrin–containing adhesion complexes in talin-depleted cells. 
Error bars indicate SEM. Bars, 15 µm.
in the adhesion complexes of talin-depleted MECs (Fig. 4 A, 
top), even though its total levels were similar to control cells 
infected with GFP-only virus or mock-infected cells (Fig. 4 B).   
To obtain a semiquantitative estimate of vinculin and talin 
within adhesions, we compared their fluorescence intensity 
profiles  simultaneously  in  control  and  talin-depleted  MECs. 
The colocalization of vinculin with talin coincided in uninfected 
control cells, whereas the neighboring infected (i.e., GFP express-
ing) cells contained virtually no vinculin or talin (Fig. 4 A,   
top graph). We confirmed the data with total internal reflection 503 Talin’s C terminus controls cell cycle • Wang et al.
Together, these results show that knockdown of talin in 
MECs does not compromise 1 integrin activation nor does 
it prevent cell adhesion and spreading and the accompany-
ing formation of actin stress fibers. It remains possible that 
there is sufficient residual talin after knockdown to permit 
integrin activation. However, our data highlight the essential 
role for talin in coordinating the assembly of core regulatory 
proteins into epithelial adhesion complexes. The mechanism 
of cytoskeletal assembly and adhesion complex formation in 
talin-depleted cells will be followed up in the future, but for 
this study, we continued to focus on the role of talin in cell 
cycle progression.
Talin links integrins with cell cycle 
progression via FAK
From the results obtained thus far, we reasoned that talin is re-
quired in order to recruit the integrin-associated adaptor proteins 
and signaling enzymes for transducing downstream physiologi-
cal processes, such as proliferation. To test this hypothesis, we 
examined the role of FAK because genetic knockout has shown 
that it is required for efficient MEC proliferation in primary 
MEC cultures (unpublished data) as well as in mammary epi-
thelial tumors in vivo (Lahlou et al., 2007; Provenzano et al., 
2008; Pylayeva et al., 2009).
fluorescence microscopy, which eliminates background fluor-
escence by detecting epitopes only within 150 nm from the 
substratum, thus enhancing the chances to detect potentially 
hidden adhesion structures (unpublished data). As with vincu-
lin, paxillin and integrin-linked kinase (ILK) were also absent 
in talin-depleted adhesions (Fig. 4 A, second and third row). 
Moreover, ectopically expressed GFP-paxillin expressed in talin-
depleted cells was cytosolic and unable to localize to adhesion 
complexes (Fig. 4 C). We examined recruitment of adhesion 
complex proteins in cells spread on a specific ECM protein,   
fibronectin (FN), and found that they were absent in talin- 
depleted cells (Fig. 4 D).
In addition to the lack of adapter proteins, FAK, a classi-
cal adhesion signaling enzyme known to participate in prolif-
eration, was also affected by talin depletion. The talin-depleted 
cells did not show FAK in any large adhesion complexes (Fig. S4). 
pY397-FAK was absent from the adhesions of talin-depleted 
cells as were other tyrosine-phosphorylated proteins (Fig. 4 A, 
fourth and fifth row). shTln1-expressing cells contained similar 
levels of FAK to controls as determined by immunoblotting, but 
FAK failed to become phosphorylated on Y397, indicating that 
it could not be activated (Fig. 4 B). Talin-depleted adhesions 
remained free of phosphoproteins, such as p-paxillin, even over 
a period of several days.
Figure 3.  Cell cycle is defective in talin-depleted MECs regardless of their spread size. (A) GFP-only or shTln1-infected MECs were replated, cultured over-
night, and labeled with BrdU. Infected cells were visualized by GFP fluorescence, and the area of cell spreading was quantified and divided into seven 
groups ranging from <50 to >300 µm
2. (left) Size distribution. (right) Quantification of BrdU staining. White bars: GFP-only infected cells. Black bars: 
GFP/shTln1-infected cells. (B) GFP-only or shTln1-infected MECs were replated on FN-coated micropatterned coverslips and then cultured overnight so that 
the cells spread to the same extent. They were then labeled with EdU. (left) Representative images. Note that the cells expressing shTln1 were defective in 
proliferation. (right) Quantification of proliferation data. Error bars indicate SEM. Bar, 15 µm.JCB • VOLUME 195 • NUMBER 3 • 2011   504
Figure 4.  Talin1 is required for recruitment of adhesion complex proteins. (A) GFP-positive talin1-deficient cells were replated (overnight) and coimmuno-
stained for vinculin (vin), paxillin (pax), ILK, pFAK, or pY20 together with antitalin–Alexa Fluor 568. GFP-expressing cells lack talin (encircled by yellow 
lines), whereas the adjacent uninfected cells contain talin adhesions. Fluorescence intensity profiles, to the right of the fluorescence images, depict the area 
of the line drawn in image overlays. (B) FACS-sorted mock-infected, GFP-only, or shTln1-infected cells were immunoblotted for adhesion proteins. (C) GFP-
paxillin was expressed in MECs together with either shTln1 or control pSilencer. GFP-paxillin localizes to talin-containing adhesions in control cells (white 
arrows). In talin-depleted cells, GFP-paxillin does not localize to adhesions and is cytosolic. Red arrows point to talin in an adjacent untransfected cell.   
(D) MECs transduced with shTln1 were replated onto FN-coated coverslips, and after 48 h, the cells were immunostained for vinculin, paxillin, or talin. 
Note the absence of vinculin and paxillin in talin (Tln)-depleted cells. Bars: (A) 15 µm; (C and D) 10 µm.505 Talin’s C terminus controls cell cycle • Wang et al.
To investigate whether talin depletion affects cell cycle 
progression via FAK, we expressed in talin-deficient cells, a 
myristoylated FAK (myrFAK), which targets FAK to mem-
branes. myrFAK localized to MEC focal adhesions and also 
associated with integrin adhesions in talin1-depleted cells 
(unpublished data). Because endogenous FAK was unable to 
be recruited to adhesions of talin-depleted cells, this strategy 
allowed us to determine whether FAK, artificially recruited to 
adhesion sites in the absence of talin, might be involved in cell 
cycle control. We found that wild-type myrFAK (wt-myrFAK), 
but not an autophosphorylation site mutant, mutant myrFAK 
(mu-myrFAK), rescued the defect in DNA synthesis as mea-
sured by EdU incorporation (Fig. 5 A).
To  identify  possible  downstream  mechanisms  linking   
talin to DNA synthesis, we tested whether talin depletion affected 
either growth factor signaling and/or cell cycle proteins. MECs 
respond to growth factors via extracellular signal–regulated 
kinase (Erk) and Akt, both of which are necessary for cell cycle 
progression.  However,  neither  Erk  nor  Akt  phosphorylation 
were compromised in talin-depleted cells (Fig. 5 B). Src also 
remained phosphorylated, even though FAK was dephosphory-
lated in the same cells (Fig. S5). Similarly, the levels of most 
of the cell cycle regulators that we were able to measure by 
immunoblotting were talin independent (Fig. 5 C, top two sec-
tions). However, one protein, p21, did stand out as being up-
regulated in the talin-depleted cells (Fig. 5 C, third section).
p21 inhibits Cdks, thereby directly suppressing progres-
sion through the G1/S phases of the cell cycle, and indeed, 
cyclin D1 was present at lower levels after talin depletion 
(Fig. 5 C, bottom section). We therefore reasoned that p21 
might provide the mechanistic link between talin and cell 
cycle  regulation.  To  test  this  possibility,  we  determined 
whether depleting p21 in shTln1-expressing cells could rescue 
the proliferation defect. We identified and tested the efficacy   
of an shRNA sequence for p21 (Fig. 5 D, left; Fasano et al., 
2007).  When  sh-p21  was  cotransfected  into  MECs  along 
with shTln1, it rescued the proliferation defect observed with 
shTln1 alone (Fig. 5 D, right).
We next tested whether FAK connects talin and p21 in 
cell cycle control of MECs. wt-myrFAK, but not mu-myrFAK, 
prevented p21 up-regulation in talin-depleted cells (Fig. 5 E). 
To confirm that this was a causal relationship, we again exam-
ined the ability of FAK to rescue the shTln1-induced prolif-
eration defect, but this time in the presence of overexpressed 
p21. As already noted, shTln1 blocked cell cycle progression 
in MECs, and this was alleviated by wt-myrFAK (Fig. 5 F). 
However, overexpressing p21 reversed the combined effects of 
shTln1 and wt-myrFAK, resulting in cell cycle arrest. These 
results correlate with a previous study showing that p21 medi-
ates cell cycle arrest in MECs lacking 1 integrins and suggest 
that in the absence of talin, FAK cannot be activated, leading to 
p21 up-regulation and cell cycle arrest (Li et al., 2005).
Talin’s C-terminal tail domain is required 
for epithelial cell cycle progression
To study the cell cycle role for talin in more detail, we ex-
amined whether specific regions of talin could rescue pFAK 
recruitment to adhesions and DNA synthesis. Talin’s head con-
tains a FERM (4.1 protein, ezrin, radixin, and moesin) domain 
that mediates integrin binding as well as an actin-binding site 
(ABS), whereas the rod comprises vinculin-binding sites (VBS), 
additional ABSs, a second integrin-binding site (IBS2), and a 
dimerization motif (dimerization site [DS]; Fig. 6 A; Critchley, 
2009; Gingras et al., 2010). To determine whether either the 
head or rod domains link integrins to proliferation, V5-tagged 
shTln1-resistant human talin1 fragments were expressed in talin- 
deficient MECs.
Expression  of  full-length  talin  in  talin-deficient  MECs 
rescued the phosphorylation of FAK within adhesions (Fig. 6 B, 
left) and restored DNA synthesis (Figs. 1 D and 6 B, right). By 
expressing talin fragments, we found that the talin head domain 
(TlnHD; aa 1–435) had no effect on proliferation, whereas the 
rod domain (aa 435–2,541) rescued both pFAK phosphorylation 
within adhesions and DNA synthesis (Fig. 6 B). To further dis-
sect the regions within talin’s rod domain that are involved with 
cell cycle regulation, we prepared additional talin constructs. 
The N-terminal half of talin (HDVBS; aa 1–1,975) did not   
localize to adhesion complexes, it did not lead to FAK phos-
phorylation, and neither did it rescue cell cycle progression 
(Fig. 6 C). In contrast, the C-terminal end of talin’s rod (talinC; 
aa 1,974–2,541) was able to rescue both FAK phosphorylation   
and DNA synthesis. These results suggested that talin transduces 
the downstream effects of integrins through the C-terminal region 
of its rod domain.
To  obtain  a  more  mechanistic  insight  into  the  regions 
within talinC that are required for proliferation, we performed 
detailed analysis using specific point mutations (Fig. 7 A). First, 
we mutated amino acids within talinC helix 50, which is in-
volved with  integrin binding (Gingras et al., 2009). L2094A/
I2095A disrupts the -helical structure of IBS2 and prevents 
talin recruitment to adhesions of Tln
/ fibroblasts (Moes et al., 
2007). K2085/K2089 binds two conserved outward-facing glu-
tamines in the membrane proximal region of  integrin tails, 
and the KK/DD double mutation prevents integrin binding and 
adhesion complex localization in CHO cells (Rodius et al., 
2008). However, in MECs, neither of these pairs of mutations 
prevented talinC localization to adhesions, vinculin recruitment, 
or FAK phosphorylation, and they both rescued DNA synthesis 
in talin-depleted cells (Fig. 7, B [third and fourth row] and C).
The talinC, KK/DD, and LI/AA mutants that rescued FAK 
phosphorylation and cell cycle progression also recruited vincu-
lin to adhesions (Fig. 7 B). However, TlnHD and HDVBS were 
not able to recruit vinculin (unpublished data). This suggests 
that talin’s ability to bind vinculin might be required for FAK 
phosphorylation  and  cell  cycle  progression.  TalinC  contains 
VBSs within helices 50 and 58, and a V2087G;L2091S;I2352G 
mutation reduces binding to the vinculin head (Himmel et al., 
2009). This triple mutation prevented talinC’s ability to recruit 
vinculin, precluded FAK phosphorylation, and failed to rescue 
the cell cycle defect (Fig. 7, B [fifth row] and C). Thus, the 
ability of talinC to bind vinculin is required for both FAK phos-
phorylation and proliferation.
We also examined the C-terminal end of talinC. R2526 
faces outwards in the C-terminal helix 62 and is necessary for JCB • VOLUME 195 • NUMBER 3 • 2011   506
Figure 5.  FAK links talin with the cell cycle. (A) MECs were cotransfected with shTln1 or empty vector (pSilencer [pSi]) together with vectors encoding 
wt-myrFAK-V5 (wtFAK) or an autophosphorylation site mutant, mu-myrFAK (muFAK). Replated cells were then labeled with EdU to evaluate proliferation.   
(B, left) FACS-sorted mock-infected, GFP-only, or shTln1-infected cells cultured in the continuous presence of serum were immunoblotted for signaling pro-
teins Erk and Akt. Actin is the loading control. (right) Alternatively, cells were serum starved, then treated with or without serum for 6 h, and immunoblotted 
for talin, pErk, and total Erk. (C) Cells infected as in B (left) were blotted for positive and negative Cdk regulators, the cyclins, and the Cdk inhibitors. The 
lines separate independent blots, each showing talin knockdown and loading controls for either actin or Erk. (D, left) To deplete MECs of p21, they were 
transfected with either shRNA for p21 (sh-p21) or empty pLVTHM (pLV; mock) and cultured (48 h). After sorting for GFP-positive cells, whole-cell lysates 
were immunoblotted for p21. Erk was using as a loading control. The p21 band was confirmed by virtue of its strong up-regulation in aphidicolin-treated 
cells (not depicted). (right) MECs were cotransfected with either sh-p21 or mock (pLVTHM) together with either shTln1 or pLVTHM (control for shTln1), 
cultured (48 h), and labeled with EdU. Note that shTln1 blocks proliferation, but this is rescued by cotransfection with sh-p21. (E) MECs transfected as in A 
were extracted and immunoblotted for p21. Note that shTln1 induces expression of p21, which is reversed by cotransfection with wt-myrFAK but not 
mu-myrFAK. (F) MECs were transfected with controls (pLV + pcDNA6) or with vectors for either just talin knockdown (shTln1 + pcDNA6), talin knockdown 
and wt-myrFAK rescue (shTln1 + wtFAK), or talin knockdown and FAK rescue together with excess p21 (shTln1 + wtFAK + p21). Note that talin depletion 
blocked proliferation, which was rescued by wt-myrFAK, but the rescue was prevented by overexpressed p21. Error bars indicate SEM.507 Talin’s C terminus controls cell cycle • Wang et al.
Figure 6.  The talin rod domain is required for efficient cell cycle in MECs. (A) Map of human talin1 domains, with amino acid numbers. The gray boxes 
denote constructs used for rescue experiments. The N-terminal head contains four FERM domains F0–F3. The C-terminal rod contains 62 amphipathic 
 helices, shown as ovals. The vinculin binding sites (VBS) are in orange. The positions of actin-binding sites (ABS), integrin binding sites (IBS), and the 
dimerization domain (DS) are shown. The figure was adapted from Critchley (2009). FL, full length. (B, left) MECs were cotransfected with shTln1 and vec-
tors encoding human talin1-V5 tag fusion proteins for full-length talin (tlnFL), the talin head (tlnHD), and rod domain (tlnRD). After 48 h, cells were replated 
(overnight) and costained for pFAK and V5. (right) Cells expressing human talin1 constructs with either shTln1 or empty plasmid (pSilencer [pSi]) were 
labeled with EdU to evaluate proliferation. (C, left) MECs were cotransfected with shTln1 and vectors encoding human talin1-V5 tag fusion proteins for the 
N-terminal half of talin (HDVBS) or the C-terminal portion (talinC). After 48 h, cells were replated (overnight) and costained for pFAK and V5. (right) Cells 
expressing human talinC, HDVBS, or control pcDNA6 together with either shTln1 or pSilencer were labeled with EdU to evaluate proliferation. The yellow 
lines demarcate the cell periphery. Error bars indicate SEM. Bars, 15 µm.JCB • VOLUME 195 • NUMBER 3 • 2011   508
Figure 7.  The C-terminal talin dimerization motif is necessary for cell cycle. (A) Map of talin1 C-terminal -helical bundles, with specific helix numbers 
(shown in pink if they run antiparallel), and locations of the IBS2 double helical bundle and the C-terminal ABS helical bundle coupled to the DS domain. 
Mutations within the IBS and VBS sites and the dimerization domain are as shown. Each mutant was constructed as a V5 tag fusion in pcDNA6. (B) MECs 
were cotransfected with shTln1 and vectors encoding wild-type (WT) talinC or talinC mutations in IBS (K2085D/K2089D and L2094A/I2095A), VBS 
(V2087G/L2091S/I2352G), and DS (R2526G). shTln1 together with empty pcDNA6 was used as a mock. Cells were costained for V5 (to identify 
location of transfected talinC constructs) and either pFAK (left) or vinculin (right). Note that wild-type talinC (second row) and the IBS mutants (third and 
fourth rows) localized to adhesion complexes and recruited pFAK and vinculin, whereas VBS and DS (fifth and sixth rows) did not. The yellow lines 
demarcate the cell periphery. (C) Similar cultures to B were stained for EdU, and the percentage of EdU staining in the transfected cells was determined. 
Note that there was no significant difference in proliferation between MECs with talin1-only knockdown (i.e., mock) and those expressing shTln1 together 
with talinC VBS or DS. P-values are compared with mock. (D) MECs were transfected similarly to those in B, but instead of immunostaining, GFP+ cells 
were FACS sorted, and whole-cell lysates were blotted for p21, pFAK, total FAK, talin, the V5 epitope, and Erk as a loading control. Note that the cells 
expressing shTln1 with control pcDNA6 vector (lane 2) contained no pFAK and expressed p21 (these cells are equivalent to mock in C, in which cell cycle 
was suppressed). FAK was phosphorylated, and p21 was largely abolished by rescue with wild-type talinC (lane 3) but not with talinC-DS (lane 4; these 
cells are equivalent to wild type and R2526G in C). Error bars indicate SEM. Bars, 15 µm.509 Talin’s C terminus controls cell cycle • Wang et al.
talin both to bind F-actin and to form dimers (Gingras et al., 
2008). An R to G mutation at this site prevented the ability of 
talinC to localize to adhesions and to rescue DNA synthesis in 
talin-depleted MECs (Fig. 7, B [bottom row] and C). This ex-
periment suggests that talin dimerization and actin binding are 
necessary for vinculin recruitment, FAK phosphorylation, and 
p21 suppression (Fig. 7 D).
Together, the results distinguish two separate functions 
for talin. Talin’s head binds and activates integrin (Ye et al., 
2010). However, the TlnHD failed to cause FAK phosphory-
lation within MEC adhesions or to permit proliferation, indi-
cating that this domain does not provide the essential link for 
other proteins to deliver sustained downstream signaling. In 
contrast, provided it is able to dimerize, the C-terminal region 
of talin’s tail recruits vinculin and leads to FAK phosphoryla-
tion, which activates downstream events required for prolifera-
tion. We suggest that the ability of talinC to become localized 
to adhesion complexes and, thereby, influence cell cycle pro-
gression is mediated through a cooperative binding to vinculin 
and actin and self-dimerization, which in turn is required for 
FAK phosphorylation.
Discussion
Previous studies have demonstrated that talin is important for 
integrin activation, transducing traction forces, and for sustained 
cell spreading and adhesion (Priddle et al., 1998; Giannone et al., 
2003; Tadokoro et al., 2003; Zhang et al., 2008; Kopp et al., 
2010). Here, we identified two key roles of talin in MECs. First, 
we found that talin coordinates the recruitment of the adhesion 
proteins vinculin, FAK, paxillin, and ILK to adhesion com-
plexes in these cells. Second, we discovered that the C-terminal 
tail region of talin controls cell cycle progression.
Thus, talin has several roles, all of which are central to 
integrin function. One part of the molecule, its head, mediates 
outward conformational changes to activate integrins, whereas 
another part, the rod, both links to the cytoskeleton and intra-
cellular pathways required for cell cycle progression (Fig. 8).
Talin coordinates adhesion  
complex assembly
Talin is widely viewed as a key structural protein of integrin 
adhesion complexes that both regulates the affinity of integrin 
for ECM ligands and links adhesions to the actin cytoskeleton 
(Anthis et al., 2009; Critchley, 2009; Ye et al., 2010). In MECs, 
knocking talin1 down to low levels has surprisingly minor effects 
on adhesion and spreading, and the cells retain stress fibers. This 
is in contrast to MEFs, suggesting that the spreading of epithelial 
cells is less sensitive than fibroblasts to talin knockdown (Zhang 
et al., 2008). It is possible that the low levels of talin remaining 
after knockdown are sufficient for integrin activation and for cell 
spreading. Alternatively, the results may reflect different mecha-
nisms of integrin–actin linking in different cell types (Otey et al., 
1990; Calderwood et al., 2003). For example, in MECs, interac-
tions between adhesion complexes and the cytoskeleton might 
be compensated for by other integrin-binding proteins, such as 
tensin (Liu et al., 2000; Legate and Fässler, 2009).
Because MECs remain spread after talin knockdown, we 
were able to identify which adhesion complex proteins are di-
rectly recruited by talin. This includes the cytoskeletal adaptor 
proteins, vinculin, paxillin, and ILK, and the adhesion signaling 
enzyme, FAK. Talin is the earliest component to be recruited to 
adhesions after integrin activation, suggesting that it has a key 
scaffolding function to recruit adhesion complex adaptors and 
enzymes (Partridge and Marcantonio, 2006). In myotendinous 
junctions of skeletal muscle, talin also has a role for recruitment 
of vinculin and ILK (Conti et al., 2009).
Differential targeting of the talin head  
and tail domains to adhesions of  
talin-depleted cells
The adhesions of talin-depleted MECs are able to recruit ex-
ogenous full-length V5-tagged talin but not its head domain. 
Others have found, similarly, that the talin head does not local-
ize to adhesions and cannot rescue adhesion complex forma-
tion in Tln
/ cells (Zhang et al., 2008; Himmel et al., 2009). 
This may be caused by structural constraints because the lack 
of  FAK  activation  precludes  PIPK1-–talin-F3  interactions 
or because the Rap1-GTP–interacting adaptor molecule can-
not recruit the talin head to integrins in the absence of other 
signals (Barsukov et al., 2003; Lee et al., 2009; Elliott et al., 
2010). Similarly, the N-terminal head/rod HDVBS fragment 
of talin was not recruited to adhesions in talin-depleted cells. 
This may be caused by an internal interaction between one of 
the head’s FERM domains and a 5--helical bundle in the rod, 
which precludes integrin binding if talin’s C-terminal domain 
is absent (Goksoy et al., 2008; Goult et al., 2009). Alterna-
tively, the lack of a C-terminal ABS could prevent HDVBS 
from being stretched by the cytoskeleton, preventing exposure 
Figure 8.  Talin is a bidirectional transducer of integrin signals. Our study 
reveals that talin is a bidirectional transducer of integrin signals, both ac-
tivating adhesion and regulating cell behavior. Talin’s head activates inte-
grins, providing outward conformational changes that lead to high affinity 
interactions of the extracellular portion of integrins with ECM proteins. This 
has been well established in the literature. Our new results show that talin’s 
C-terminal tail is involved in recruiting vinculin and FAK to adhesion com-
plexes and that this domain of talin is involved with cell cycle progression 
via p21 suppression. P, phosphorylation.JCB • VOLUME 195 • NUMBER 3 • 2011   510
The mechanism of FAK recruitment to integrin adhesions 
is potentially complex because it may be targeted there by a 
variety of possible FAK-interacting proteins, which could vary 
among different cell types. Our data suggest that in MECs, the 
talin C terminus is required to recruit FAK to adhesion sites. 
There are no known FAK-binding sites in the rod domain of 
talin, so it is likely that FAK binds indirectly. We have found 
that vinculin depletion in MECs largely precludes FAK phos-
phorylation  within  adhesion  sites  without  affecting  endog-
enous talin localization, so vinculin may have an indirect role 
(unpublished data).
FAK supports proliferation in many cell types (Lim et al., 
2010; Zhao et al., 2010). In the mammary gland, its role has 
been studied in tumor initiation and growth, in which FAK 
overexpression  correlates  with  a  majority  of  human  breast 
cancers, and FAK deletion slows proliferation and cancer for-
mation in animal models. The requirement for FAK in mam-
mary tumor formation is linked to phosphorylated Erk, Src, 
and Crk-associated substrate (Cas; Provenzano et al., 2008; 
Pylayeva et al., 2009). In our study, the autophosphorylation 
FAK mutant did not rescue proliferation in MECs, indicat-
ing a likely requirement for a pY397-binding, SH2-containing 
protein. Neither Erk nor Akt phosphorylation were altered in 
talin-defective MECs, suggesting that it is unlikely that the 
control point is via these pathways. This is supported by other 
studies in MECs, in which 1 integrin gene deletion or sus-
pension culture does not alter growth factor–induced Erk and   
Akt signaling (Wang et al., 2004; Naylor et al., 2005). An alter-
nate possibility is that Cas, which is activated by FAK-pY397–
bound Src and binds prolines within FAK’s C terminus, provides 
the proximal link between FAK and proliferation. Cas over-
expression causes mammary hyperplasias, and Cas–FAK inter-
actions are required for the latter’s proliferative ability in 
primary MEC culture (Cabodi et al., 2006; Pylayeva et al., 
2009). Src phosphorylation was not altered in talin-depleted 
cells, but this may not be surprising as it remains phosphory-
lated in FAK
/ MECs and can be activated independently 
by growth factor receptors (Yeatman, 2004; van Miltenburg 
et al., 2009). p190RhoGEF also connects to FAK and has a 
role in fibroblast proliferation, so this could also be involved 
together with Pyk2 (Lim et al., 2008b).
Downstream of components within the adhesion complex, 
the current literature has not fully clarified how FAK might   
control p21 levels and thereby cell cycle progression. A pos-
sible mechanism is via ubiquitination. For example, in endothe-
lial cells, FAK causes the degradation of p27 and p21, which for 
p27 is Skp2 dependent, and FAK inhibition up-regulates both 
these Cdk inhibitors (Bryant et al., 2006). Our data indicate a 
role for p21 in the integrin/talin control of MEC proliferation, 
so FAK may determine the levels of p21 either through Skp2-
independent degradation or via p53-mediated transcription (Lim 
et al., 2008a).
In summary
Our work pinpoints a central role for the C terminus of talin 
in recruiting core components to the adhesion complexes of 
MECs. This is crucial for cellular physiology because some of 
of the cryptic VBS at helix 4 and thereby recruitment to adhe-
sions (del Rio et al., 2009).
In contrast to the N terminus, the talin C-terminal tail   
domain was readily recruited to adhesion sites in cells depleted 
of endogenous talin. Candidate regions for adhesion targeting 
include an IBS, two VBSs, and the dimerization/F-actin–binding 
C terminus. Because talinC-containing mutations within the 
IBS region still targeted to adhesions of talin-depleted MECs, 
we made subtle mutations either within the C-terminal VBS 
helices 50 and 58 to prevent vinculin binding or within helix 62 
to inhibit dimerization and actin binding (Gingras et al., 2008). 
Both of these mutations prevented the ability of talinC to target 
to adhesions and to recruit vinculin. Vinculin has a key role in 
linking adhesions with F-actin, suggesting that the vinculin-
binding ability of talinC might contribute to adhesion targeting 
(Humphries et al., 2007). Being that talinC binds to F-actin 
within  adhesion  complexes,  rather  than  broadly  decorating 
stress fibers, our data suggest that talinC requires cooperative 
binding to vinculin, integrin, and actin to be targeted to adhe-
sion sites.
Talin links integrins with cell cycle 
progression via FAK
The observation that talin knockdown inhibits cell cycle pro-
gression reveals a key role for talin in controlling cell signal-
ing. The experiments in which we forced cells to spread on 
FN-coated islands of defined size indicate that the inhibition 
of proliferation in talin-depleted cells is not a result of the 
cells being unable to adhere to ECM substrata via integrins or 
to spread appropriately on the ECM (Chen et al., 1997). By 
depleting talin in MECs to such a level that integrins remain 
active and the cells can spread on ECM, we were able to un-
cover a correlation between recruitment of adhesion complex 
proteins and proliferation.
Integrins are crucial for cell cycle in the mammary gland. 
1 integrin gene deletion in vivo inhibits the proliferation of 
MECs, with a concomitant decrease of FAK activity and an in-
crease of p21 expression (Li et al., 2005). The link between 
integrin, p21, and cell cycle was confirmed genetically in that 
study, and we have now extended those conclusions by identi-
fying a pathway connecting integrin with p21 expression.
Several lines of evidence in our study suggest that FAK 
might be a candidate for linking talin with proliferation. First, 
endogenous FAK is phosphorylated in the adhesions of shTln1 
cells expressing only the talin constructs that rescue cell cycle 
progression. Second, membrane-targeted FAK colocalizes with 
integrin adhesions, and the wild type, but not an autophosphory-
lation mutant, rescues proliferation in the absence of talin. Third, 
the rescue of proliferation by myrFAK is suppressed by additional 
expression of p21. Fourth, p21 is up-regulated in talin-depleted 
cells, and this is reversed by wild type, but not mutant, myrFAK. 
Fifth, shTln1-induced p21 expression is suppressed by talinC but 
not a mutant that cannot rescue proliferation, and finally deplet-
ing p21 rescues the proliferation defect in the absence of talin. 
Together, these results delineate an integrin-mediated pathway 
via talin and FAK that is required in MECs to suppress p21 and 
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these proteins are adaptors that link ECM–integrin interactions 
to distal cell fate decisions. In the current study, we uncovered 
a role for talin in linking integrins with proliferation, and our 
data delineate an integrin–talin–FAK pathway required for p21 
suppression. Talin also has a role in cell cycle regulation of 
a metastatic mammary cancer line, 4T1, lending credence to 
the idea that targeting proteins downstream of integrins might 
represent a therapeutic route of intervention in cancer patients.   
Future  studies  will  focus  on  the  molecular  mechanisms  by 
which talinC is recruited to adhesion complexes, how vinculin 
and FAK are recruited to adhesions by talinC, and the pathways 
downstream of adhesion complexes that determine p21 levels 
and cell cycle progression in MECs.
Materials and methods
Cell culture
FSK7 is a mouse MEC strain isolated from luminal epithelial cells and was 
used at a low passage number (Kittrell et al., 1992). FSK7 cells were cultured 
in DF12 medium (BioWhittaker; Lonza) supplemented with 5 ng/ml EGF, 
880 nM insulin, and 2% FCS at 37°C in a humidified atmosphere of 5% 
CO2. Primary MECs were extracted from 19-d pregnant mice and cultured in 
growth medium containing 5 µg/ml insulin, 1 µg/ml hydrocortisone, 3 ng/ml 
EGF, 10% FCS, 50 U/ml penicillin/streptomycin, 0.25 µg/ml fungizone, and 
50 µg/ml gentamycin in F12 medium (Pullan and Streuli, 1996). For grow-
ing lentivirus, 293T was cultured in DME supplemented with 10% FCS.
DNA constructs
shRNA for talin1 was designed with siRNA Target Finder (Invitrogen), and 
the sequences used were shTlnA, 5-AAGAAGCACAGAGCCGATTGA-3, 
and shTlnB, 5-AAGAACAAGATGGATGAATCA-3. The scrambled shRNA 
sequence for talin1 contained the same nucleotides as those for shTlnA, 
5-GACAGATGAGGAGCAATCACA-3, and this sequence did not reveal 
any known targets by a BLAST (basic local alignment search tool) search. 
The shRNA sequence for p21 was 5-TTAGGACTCAACCGTAATA-3. The 
shRNAmir for 1 integrin was 5-GGCTCTCAAACTATAAAGAAA-3 (pro-
vided by P. Stern, Massachusetts Institute of Technology, Cambridge, MA).
Doubled-stranded  oligonucleotides  were  cloned  into  the  shRNA 
transfer vectors pSilencer 3.1 (Invitrogen) or pLVTHM (Tronolab). pLVTHM 
was used in most of the experiments and was used to generate lentiviruses. 
In a few experiments, the same sequences in pSilencer, which does not 
also express GFP, were used in transfection experiments, and the empty 
vector was used as a control (Figs. 5, A and E; and 6, B and C, pSi). The 
extent of knockdown with pSilencer is the same as for pLVTHM. In the case 
of sh–1 integrin-mir, the transfer vector was pLB2Cap2Gm (pLB2).
For rescue vectors, human full-length wild-type talin1 cDNA was ob-
tained from Source BioScience LifeSciences. To avoid deletion by shTln1, 
specific mutations were created by using site-directed PCR and mutagenic 
oligonucleotides (QuikChange; Agilent Technologies). The shRNA target 
sequence for mouse talin1 is nucleotides 3,707–3,728, which contains 
two variations from the corresponding human talin1 sequence (A → T and 
A → G), and additional G → A and C → T mutations were placed in the 
human talin1 sequence (no amino acid change). The plasmids containing 
shTln1-resistant human talin1 or FAK constructs were cotransfected with 
pLVTHM-shTln1 using Lipofectamine plus (Invitrogen).
Full-length talin (aa 1–7,623), head domain (aa 1–1,305), and rod 
domain (aa 1,305–7,623) as well as HDVBS (aa 1–5,925) and talinC 
(aa 5,922–7,623) were cloned into pcDNA6/V5-His(A) (Invitrogen). 
Additional talinC mutants described in this paper were created by using 
site-directed PCR and mutagenic oligonucleotides.
wt-myrFAK or an autophosphorylation-site Y397F mutant form of 
FAK (mu-myrFAK) was generated by cloning the viral Src myristoylation 
sequence N terminal to the FAK coding sequence in pcDNA6/V5-His(A) 
and provided by A. Gilmore (University of Manchester, Manchester, Eng-
land, UK). Full-length p21 cDNA (Thermo Fisher Scientific) was generated 
in pCMV-SPORT6.
Lentiviral infection
The lentiviral shRNA system was provided by D. Trono (University of Geneva, 
Geneva, Switzerland). For lentivirus production, the transfer vectors were 
cotransfected with the envelope plasmid pMD2G and the packaging plasmid 
psPAX2 by the calcium phosphate method into 293T cells that had been pre-
cultured for 8–16 h. Media were replaced after 8–10 h. 10 ml viral super-
natants was harvested 48–60 h after transfection, passed through a 0.45-µm   
filter, and further concentrated by centrifugation at 25,000 rpm at 4°C   
for 2.5 h. Viral pellets were resuspended in 0.1 ml fresh DF12 medium.
Lentiviral infection was performed by adding the appropriate amount 
of lentiviral particles directly to precultured 75% confluent cells. Dishes 
were spun at 3,000 rpm at 37°C for 20 min to increase the infection rate 
followed by incubation for 3 h. The infected cells were cultured for 48–72 h 
before being replated for further experiments. This protocol was necessary 
to ensure turnover of preexisting talin.
Depending on the batch of lentivirus, we normally obtained a 70–100%   
efficiency of infection in MECs. For some experiments, we FACS sorted the 
GFP+ cells to enrich to 100% infected cells for the endpoint assays.
Immunofluorescence
Cells were fixed with 4% formaldehyde for 10 min, permeabilized for   
5 min with 0.5% Triton X-100 (Sigma-Aldrich), and subsequently incubated 
for 1 h with primary antibodies directed against the proteins indicated in 
this section followed by the appropriate conjugated secondary antibodies 
(Jackson ImmunoResearch Laboratories, Inc.). For actin fluorescence stain-
ing, Alexa Fluor 647–phalloidin (Invitrogen) was added to cells together 
with the secondary antibody. For integrin staining, cells were briefly treated 
with 0.5% CHAPS before fixing.
In  the  case  of  costaining  for  talin1  with  the  other  monoclonal 
antibodies for vinculin, paxillin, ILK, and Py20, the antitalin antibody 
was preconjugated to Alexa Fluor 548 by using a monoclonal antibody- 
labeling kit (Invitrogen). Cells were incubated with monoclonal antibodies   
followed by a Cy5-conjugated donkey anti–mouse fragment antigen-
binding region (Jackson ImmunoResearch Laboratories, Inc.), fully washed   
with PBS, and then the Alexa Fluor 548–antitalin antibody was added 
to stain talin1. Antibodies used for immunostaining were as follows:   
1 integrin (Klinowska et al., 1999); FAK (a gift from L. Romer, Johns 
Hopkins University School of Medicine, Baltimore, MD); 9EG7, paxillin, 
and py20 (BD); pFAK-Y397 (Invitrogen); V5 and GFP (Invitrogen); sec-
ondary mouse Cy2 and Rhodamine Red-X (Rhrx), rabbit Cy2 and Rhrx, 
and rat Rhrx (Jackson ImmunoResearch Laboratories, Inc.); talin and 
vinculin (Sigma-Aldrich); and ILK (Millipore).
After staining, coverslips were mounted with antifade reagent (Pro-
Long;  Invitrogen).  Images  were  acquired  on  a  restoration  microscope 
(DeltaVision RT; Applied Precision) using either a 100×/1.40 Uplan S Apo-
chromat or a 60×/1.42 Plan Apochromat objective and the Sedat filter set 
(89000; Chroma Technology Corp.). The images were collected using a 
camera (CoolSNAP HQ; Photometrics) with a z optical spacing of 0.2 µm. 
Raw images were then deconvolved using the softWoRx software (Applied 
Precision), and maximum intensity projections of these deconvolved images 
are shown in the Results and followed by analysis with ImageJ 3.4 (National 
Institutes of Health) or Openlab 4 software (PerkinElmer).
Immunoblotting
Equivalent amounts of protein were separated by SDS-PAGE and immuno-
blotted for proteins. Detection was achieved with peroxidase-conjugated 
anti–rabbit, anti–goat, and anti–mouse IgG (Jackson ImmunoResearch Lab-
oratories, Inc.) followed by enhanced chemiluminescence (GE Healthcare). 
Antibodies  different  to  those  used  in  immunostaining  were  as  follows:   
talin1- and talin2-specific antibody (a gift from D.R. Critchley, University of 
Leicester, Leicester, England, UK); FAK (a gift from A. Ziemiecki, University 
of Bern, Bern, Switzerland); p21 (BD); pY31-paxillin (Invitrogen); pT202/
Y204-p42/44-MAPK, Akt, pS473-Akt, pY416-Src, and pY527-Src (Cell 
Signaling Technology); c-myc (Roche); cyclin A, cyclin D1, Cdk2, Erk2, 
Src, p16, and p27 (Santa Cruz Biotechnology, Inc.); and actin and p57 
(Sigma-Aldrich).
Adhesion assay
Cell adhesion experiments were performed as previously described (Edwards 
and Streuli, 1999). In brief, wells of 96-well plates were precoated with 
ECM proteins as indicated 4°C overnight. After blocking with 0.5% bovine 
serum albumin, 10
5 cells were added into wells in triplicate and incu-
bated for 2 h at 37°C. Wells were washed with PBS, and the adherent 
cells were quantified by labeling with 5 mg/ml Crystal violet (Sigma- 
Aldrich) and reading the absorbance at 595 nm.
dU incorporation
Replated cells were cultured for 16 h and then labeled with either 10 µM 
BrdU or EdU for 2 h before fixation. Cells were stained with either anti-
BrdU antibodies or with the EdU Alexa Fluor 647 imaging kit (Click-iT;   JCB • VOLUME 195 • NUMBER 3 • 2011   512
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